SEngine Precision Medicine Company
SEngine Precision Medicine uses algorithms and 3D organoid technology to develop drugs with more efficacy.
Founded Date:
2015-01-01
Total Funding:
21200000.0
Employee Number:
11-50
Funding Status:
Early Stage Venture
Technology:
Biotechnology
Last Funding Type:
Series A
Investors Number:
5.0
Last Funding Date:
2022-07-28
Industry:
Early Drug Development
Headquarters:
Seattle, Washington, United States
Estimated Revenue:
$1M to $10M